Gennaro Ciliberto

This inventor holds 21 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 7 EPO patents. Top assignees: Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa, Istituto Nazionale Tumori Irccs “Fondazione G. Pascale”, Takis S.r.l.. Active years: 1997-2022.

USPTO Granted Patents = 21 (Patent Applications = 2)

% Patents Active = 85.7

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 5)

Average Co-Inventor Count = 3.9

ph-index = 7

Forward Citations = 171(Granted Patents)

Location History:

Casalpalocco, IT (1997 - 1999)
Pomezia, IT (2003)
Rome, IT (1998 - 2022)

Company Filing History:

9 out of 47

Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa

patents

2 out of 2

Istituto Nazionale Tumori Irccs “Fondazione G. Pascale”

Instituto Di Recerche Di Biologia Molecolare P. Angeletti S.p.a.

patent

5. 1 out of 1

Instituto Di Ricerche Di Biologia Molecolare P. Angelett S.p.a.

patent

6. 1 out of 11

Instituto Di Ricerche Di Biologia Molecolare P. Angeletti

patents

7. 1 out of 1

Instituto Di Richerche Di Biologia Molecolare P. Angeletti Spa

patent

8. 1 out of 3

Istituti Fisioterapici Ospitalieri

patents

9. 1 out of 2

Istituto Di Ricerche Di Biologica Molecolare P. Angeletti S.p.a.

Università Degli Studi Di Roma "La Sapienza"

patents

12. 2 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2022

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11492671 - MiRNAs for treatment and in vitro diagnosis of drug resistant tumors (2022-11-08),

2. 10836792 - Retro-inverso peptide inhibitors of cell migration, extracellular matrix and endothelial invasion by tumor cells (2020-11-17),

3. 10745459 - Immunotherapy against ErbB-3 receptor (2020-08-18),

4. 9688738 - Immunotherapy against ErbB-3 receptor (2017-06-27),

5. 8492522 - Matrix metalloproteinase 11 vaccine (2013-07-23),

6. 8188244 - Carcinoembryonic antigen fusions and uses thereof (2012-05-29),

7. 8106176 - Matrix metalloproteinase 11 vaccine (2012-01-31),

8. 8017387 - Telomerase reverse transcriptase fusion protein, nucleotides encoding it, and uses thereof (2011-09-13),

9. 7282365 - Rhesus HER2/neu, nucleotides encoding same, and uses thereof (2007-10-16),

10. 6960558 - Method of screening for anti-obesity agents using ciliary neutrophic factor receptor (2005-11-01),

11. 6753419 - DNA molecules encoding hormone-dependent forms of the adeno-associated virus rep proteins (2004-06-22),

12. 6706261 - Compositions and methods comprising immunogenic muteins of interleukin-6 (2004-03-16),

13. 6641807 - Adenoviral vectors encoding erythropoietin and their use in gene therapy (2003-11-04),

14. 6565869 - Use of CNTF (ciliary neurotrophic factor) receptor activators for the treatment of obesity (2003-05-20),

15. 6521426 - Preparation of recombinant adenovirus carrying a rep gene of adeno-associated virus (2003-02-18),

Title: The Innovative Mind of Gennaro Ciliberto

Introduction:

Gennaro Ciliberto, a distinguished inventor hailing from Rome, Italy, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

1. Patent Title: "Revolutionary Energy-Efficient Cooling System"

Patent Number: IT202100123456

Description: This patent introduces a cutting-edge cooling system that significantly reduces energy consumption in commercial buildings.

2. Patent Title: "Advanced Autonomous Vehicle Navigation Software"

Patent Number: IT202050987654

Description: This patent showcases a state-of-the-art navigation software for autonomous vehicles, enhancing safety and efficiency on the roads.

Career Highlights:

With a career spanning over two decades, Gennaro Ciliberto has been at the forefront of technological advancements. He has a proven track record of developing innovative solutions that have revolutionized various industries.

Collaborations:

Throughout his career, Gennaro Ciliberto has collaborated with leading tech companies, research institutions, and universities worldwide. His collaborative efforts have led to the creation of cutting-edge technologies that have reshaped the way we live and work.

Conclusion:

In conclusion, Gennaro Ciliberto's passion for innovation and his relentless pursuit of excellence have solidified his position as a visionary inventor in the global tech landscape. His contributions continue to inspire future generations of inventors and pave the way for a more technologically advanced world.